BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...

This eases the user's understanding of the market thoroughly, while also gaining knowledge about Anxiety Disorder Treatment market opportunities and the dominant players Pfizer Inc, Merck KGaA ...

Chronic Lower Back Pain (CLBP) market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

Joe Biden and Donald Trump pledged to deliver a “smooth” transfer of power in the US as they met in the Oval Office for the first time since last week’s presidential election. “Congratulations,” Biden ...

Read the Market Summary Here @- India Animal Vaccine Market Size Zooming 3.6X at Healthy CAGR of More Than 7% to Surpass USD 4.87 Billion and 376.1 Million Doses by 2030 India Animal Vaccine Market ...

It said it saw BNT327’s dual-target approach as a significant advancement over single-action therapies like Merck’s Keytruda ...

As Modern Healthcare reports, CMS has relaxed supervision requirements for physical and occupational therapist assistants from “direct” to “general.” The change could help health systems manage ...

Most recently, he served as Chief Operating Officer of Prometheus Biosciences, a biotechnology company focused on gastrointestinal diseases that was acquired by Merck for $10.8 billion in 2023. Prior ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...